| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2858411320fb0a2e0a846742666185f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3852 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
| filingDate |
2000-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb1cc3eccc0d66d4c264136d554d3597
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb3b8ba77d80c2e780ac99f0a87866a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5a001d0ada9bf36ef748c6586895f1d |
| publicationDate |
2001-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1085082-A1 |
| titleOfInvention |
Methods and compositions for chondrocytes preservation and uses therefor |
| abstract |
The present invention relates to compositions of chondrocytic cells,nespecially human, and methods for their preparation andnuses. The invention more particularly describes the production of suspensionsnautologous human chondrocytes using recombinant enzymesnand / or media compatible with pharmaceutical use. The invention describesnalso methods and compositions for freezing chondrocytes,nespecially in the absence of DMSO. The chondrocytes produced can benused in vivo to restore affected cartilage structures, such asnpost-traumatic cartilage defects or dissecting osteochondritis of thenknee or, more generally, for the treatment and repair of defectsnclinically significant cartilage, especially articular cartilage. |
| priorityDate |
1999-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |